Ultimately, there is a pressing need to understand whether the beneficial indirect effects of GLP-1RA medications on pancreatic diseases, including PDAC (e.g., weight loss), are negated by direct effects on the pancreas
However, genetically related donors exhibited a significant advantage in graft survival rates at 1 year (p 0.05)
But while theyre effective, many users experience mild skin irritation, redness, or tenderness at the injection site
Blevins et al., 2011)
PubMed, Embase, and the Cochrane Library were searched using keyword combinations related to GLP-1 receptor agonists, dual GLP-1/GIP agonists, and GI adverse events, from the inception of the database up to March 2025
R.DebeliusJ